Nigeria’s Chekkit gets picked for 2020 cohort of Merck accelerator

Real-time verification startup Chekkit, is one of the 12 startups participatin in the 8th edition of Merck Accelerator.

Merck Accelerator, launched by German healthcare firm, Merck Group, provides promising startups with three months of training by industry experts and US$ 55, 000 in funding. In addition to this they are granted the opportunity to join the Merck China Innovation Hub in Shanghai for an extension of the program.

Related article: Chekkit is an Anti-Counterfeiting, Assets Tracking and Consumer Feedback Analytics Tool- Dare Odumade, CEO-Chekkit Technologies

Chekkit makes the cut out of 503 applicants from 65 countries.

Chekkit provides real-time verification of quality products, consumer intelligence and supply chain tracking services to producers of high-quality human-friendly products, to ensure complete product integrity.

Merck Accelerator Head, Munya Chivasa, said, “Working with startups has brought numerous opportunities to different areas of Merck and we are constantly adapting and evolving these programs to make them even more fruitful for both sides.”

The other 11 startups selected for the accelarator alongside Chekkit are;

1. ATLANT 3D Nanosystems
2. breathe ilo (Austria)
3. CCG.ai (UK)
4. Cellular Agriculture Ltd (UK)
5. Instant NanoBiosensors (Taiwan)
6. Lab Fam Foods (US)
7. ProbiusDx Inc. (US)
8. Qfluidics (France)
9. SEED Biosciences SA (Switzerland)
10. Tymora Analytical Operations (US)
11. Xsensio (Switzerland)

Chekkit is the only African country to make the cut.